The Global Gene Editing Technologies In Diagnostic Platforms Market Report is a compilation of comprehensive research studies of various aspects of the Gene Editing Technologies In Diagnostic Platforms Market. With accurate data and highly authentic information, a brilliant attempt is made to paint a true, transparent picture of the current and future situations of the global Gene Editing Technologies In Diagnostic Platforms market. Market participants can use this powerful tool when creating effective business plans or making major changes to their strategies. The report discusses the growth of the global as well as regional markets. It also throws light on high-growth segments of the global Gene Editing Technologies In Diagnostic Platforms market and how they will evolve in the years to come.
Read Detailed Index of full Research Study @ https://www.absolutemarketsinsights.com/reports/Gene-Editing-Technologies-in-Diagnostic-Platforms-Market-2019-2027-477
In terms of revenue, the global gene editing technologies in diagnostic platforms market was valued at US$ 2,133.3 Mn in 2022 and is expected to reach US$ 7,004.8 Mn by 2030 growing at a CAGR of 14.4% over the forecast period.. Beam Therapeutics, Bio-Connect Group, CRISPR Therapeutics, Editas Medicine, GeneCopoeia, Inc., GenScript, Horizon Discovery Ltd., Inscripta, Inc., Integrated DNA Technologies, Inc., Intellia Therapeutics, Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs, OriGene Technologies, Inc., Pairwise, Precision Biosciences, Sangamo Therapeutics, STEMCELL Technologies Inc., Thermo Fisher Scientific Inc., Transposagen Biopharmaceuticals, Inc.
Gene editing technologies in diagnostic platforms means adoption of gene editing in diagnostic platform to cure the diseases such as single-gene disorders such as cystic fibrosis, haemophilia, and sickle cell disease. Research is going on about gene editing to heal complex diseases such as cancer, heart disease, mental illness, and human immunodeficiency virus (HIV) infection, thereby expected to support the gene editing technologies in diagnostic platforms market growth.
The rise in the deoxyribonucleic acid (DNA) synthesis technology is driving growth of the gene editing technologies in diagnostic platforms market. CRISPR-Cas9 is a powerful genome editing tool. The demand for DNA synthesis technology is on the rise due to the development of CRISPR-Cas9. For example, Evonetix, a company based in Cambridge, U.K., is developing a silicon lab-on-chip system which is a desktop platform for highly equivalent, precise, and scalable DNA synthesis that will enlarge the horizons of synthetic biology.
Moreover, technological advancements in gene editing will further drive growth of the gene editing technologies in diagnostic platforms market. For example, a recent technological advancement in CRISPR can mutate entire DNA in one step. Earlier, CRISPR could only target single gene for editing. This new discovery will shorten the time gap to find the cure for deadly diseases.
However, these technological advancement can pose a big threat to individuals which may impede the growth of the gene editing technologies in diagnostic platforms market over the forecast period. For example, the simplicity and low-cost tools for gene editing will allow the amateurs or biohackers to perform their own experiments which will pose the potential risk from the release of genetically modified bugs. Moreover, the modification in the genes may harm the child as well as their future generations because the altered gene would be present in their sperm or eggs. Due to the related risks, mutating the human embryo and transplanting it to the women is banned in Britain. In November 2018, the Chinese team became the first in the world to edit human embryos. When they tried and failed to mutate the gene, it caused beta-thalassemia, a potentially fatal blood disorder. It was performed on the abnormal In vitro fertilization (IVF) embryos donated for research.
The use of genome editing in personalized medicine is likely to support the gene editing technologies in diagnostic platforms market growth during the forecast period. For example, the CRISPR-CAS9 system can be used to treat respiratory diseases as well as other ailments.
Moreover, gene editing is used to treat various complex ailments like cancer, blood disorders, blindness, acquired immune deficiency syndrome (AIDS), cystic fibrosis, Duchenne muscular dystrophy, Huntington’s disease, among others, which is difficult or nearly impossible to cure otherwise is driving the gene editing technologies in diagnostic platforms market growth in the near future.
However, gene therapy is very expensive which can impede growth of the gene editing technologies in diagnostic platforms market during the study period. For example, according to the news published on the Independent website, the cost of the therapy ranges from $500,000 to $1.5m and over a lifetime, drugs like nusinersen can be even more expensive which is about $750,000 in the first year followed by $375,000 in the second year for the lifetime.
Gene Editing Technologies in Diagnostic Platforms Market:
- By Technology
- By Application
- Cell Line Engineering
- Genetic Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
- By End User
- Biotechnology & Pharmaceutical Companies
- Academic and Research Institutions
- Contract Research Organization (CROs)
- By Geography
- North America
- Rest of North America
- The UK
- Nordic Countries
- Benelux Union
- The Netherlands
- Rest of Europe
- Asia Pacific
- New Zealand
- South Korea
- Southeast Asia
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
- Latin America
- Rest of Latin America
- North America
Besides target market information, Absolute Markets Insights also provides information about your competitor, your customers, products etc. A few techniques we use are:
- Customer analysis
- Competitor analysis
- Risk analysis
- Product research
- Advertising research
- E-mail survey and many more…
- Market Research Methodology
We define the research problem: The step defining the research problem exists of two main steps:
- Formulating the problem
- Establishing research objectives
- Selecting and Establishing Research Design
The step selecting and establishing research design consists of three main steps:
- Select the research design
- Identify information types and sources
- Determine and design research instrument
Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: [email protected]
Phone: IN +91-7400-24-24-24, US +1-510-420-1213